Caprelsa

Lilly’s Retevmo Shows Superior Survival in Phase III Thyroid Cancer Trial
BioSpace
Wed, 08/23/23 - 10:12 am
Eli Lilly
Retevmo
thyroid cancer
medullary thyroid cancer
clinical trials
Exelixis
Capometyx
Sanofi
Caprelsa
AstraZeneca sells rare cancer drug to Sanofi for up to $300 million
Yahoo/Reuters
Mon, 07/27/15 - 10:00 am
AstraZeneca
Sanofi
Caprelsa
medullary thyroid cancer
Tackling Cancer: Thyroid Cancer's Biggest Current and Upcoming Players
Motley Fool
Mon, 04/29/13 - 05:24 pm
thyroid cancer
Caprelsa
AstraZeneca
Cometriq
Exelixis
Nexavar
Bayer
ONYX Pharmaceuticals
JAMA says FDA jumped the gun on Gilenya, Pradaxa
Fierce Pharma
Thu, 09/6/12 - 09:33 am
JAMA
FDA
Pradaxa
Gilenya
Caprelsa
Boehringer Ingelheim
Novartis
AstraZeneca
First Orphan Launch a Challenge for AstraZeneca
PharmExec
Thu, 08/4/11 - 09:55 am
AstraZeneca
Caprelsa
vandetanib
thyroid cancer
Zactima